Occam

Sales & Marketing

John Holodnak, co-founder of Occam, discusses how AI is beginning to reshape career paths across life sciences.

News

Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in sickle cell disease.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.